Recommendations for the management of intracranial arteriovenous malformations: A statement for healthcare professionals from a special writing group of the stroke council, American Stroke Association

Stroke

Volumn 32, Issue 6, 2001, Pages 1458-1471

  Ogilvy, C S ^a   Stieg, P E ^a   Awad, I ^a   Brown R D , Jr ^a   Kondziolka, D ^a   Rosenwasser, R ^a   Young, W L ^a   Hademenos, G ^a  

^a AMERICAN HEART ASSOCIATION   (United States)

Author keywords

AHA Scientific Statements; Arteriovenous malformations; Cerebrovascular disease; Hemorrhage; Stroke

Indexed keywords

BRAIN ARTERIOVENOUS MALFORMATION; BRAIN EDEMA; BRAIN HEMORRHAGE; CLINICAL FEATURE; NEUROSURGERY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STROKE; ARTICLE; ARTIFICIAL EMBOLISM; CEREBRAL REVASCULARIZATION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; FEMALE; HEADACHE; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; MEDICAL SOCIETY; MULTIMODALITY CANCER THERAPY; NETHERLANDS; PREVALENCE; RADIOSURGERY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEIZURE; STANDARD; STATISTICS; TREATMENT OUTCOME; UNITED STATES;

ANTIHYPERTENSIVE AGENT;

AMERICAN HEART ASSOCIATION; ANTIHYPERTENSIVE AGENTS; CEREBRAL REVASCULARIZATION; COHORT STUDIES; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; FEMALE; HEADACHE; HUMANS; INCIDENCE; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; INTRACRANIAL HEMORRHAGES; MALE; MINNESOTA; NETHERLANDS; PREVALENCE; RADIOSURGERY; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SEIZURES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0034991811     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.32.6.1458     Document Type: Review

References (189)

1. Rules of evidence and clinical recommendations on the use of antithrombotic agents
2. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association
3. Natural history and pathophysiology of arteriovenous malformations
4. Arteriovenous aneurysms of the brain: Their diagnosis and treatment
5. Arteriovenous malformations of the brain in adults
6. Cerebral arteriovenous malformations in the Netherland Antilles: High prevalence of hereditary hemorrhagic telangiectasia-related single and multiple cerebral arteriovenous malformations
7. Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992
8. Revisited old and new CT findings in unruptured larger arteriovenous malformations of the brain
9. Intracranial vascular malformations: MR and CT imaging
10. Intracranial aneurysms and vascular malformations: Comparison of time-of-flight and phase-contrast MR angiography
11. Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: A population-based study of intracranial vascular malformations in Olmsted County, Minnesota
12. Occurrence of severe vasospasm following intraventricular hemorrhage from an arteriovenous malformation
13. The natural history of unruptured intracranial arteriovenous malformations
14. Natural history of intracranial vascular malformations: A review
15. "Steal" is an unestablished mechanism for the clinical presentation of cerebral arteriovenous malformations
16. The decreasing incidence of primary intracerebral hemorrhage: A population study
17. Bleeding from cerebral arteriovenous malformations as part of their natural history
18. Natural history of arteriovenous malformations of the brain: A clinical study
19. Arteriovenous malformations of the brain: The natural history in unoperated patients
20. Arteriovenous malformations of the brain: A long-term clinical study
21. The natural history of symptomatic arteriovenous malformations of the brain: A 24 year follow-up assessment
22. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation
23. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation
24. Simple risk predictions for arteriovenous malformation hemorrhage
25. Simple risk predictions for arteriovenous malformation hemorrhage
26. The change in size of intracranial arteriovenous malformations
27. Feeding artery pressure and venous drainage pattern are primary determinants of hemorrhage from cerebral arterlovenous malformations
28. Hemorrhage in intracerebral arteriovenous malformations: Angiographic determinants
29. Cerebral physiology and the effects of anesthetic agents and techniques
30. The acute treatment of cerebral arteriovenous angiomas associated with hematomas
31. Correlation of the angioarchitextural features of cerebral arteriovenous malformations with clinical presentation of hemorrhage
32. An analysis of the venous drainage system as a factor in hemorrhage from arteriovenous malformations
33. The influence of hemodynamic and anatomic factors on hemorrhage from cerebral arteriovenous malformations
34. Intracranial arteriovenous malformations associated with aneurysms
35. Factors that predict the bleeding risk of cerebral arteriovenous malformations
36. AVM of the brain: Clinical considerations, general and special operative techniques, surgical results, nonopemted cases, cavernous and venous angiomas
37. Cerebral physiology
38. A proposed grading system for arteriovenous malformations
39. Surgical excision of cerebral arteriovenous malformations: Late results
40. A new grading system for cerebral arteriovenoas malformations
41. A proposed scheme for grading intracranial arteriovenous malformations
42. Determinants of resource utilization in the treatment of brain arteriovenous malformations
43. The prospective application of a grading system for arteriovenous malformations
44. Zum prognostischen wert von graduier-ungssystemen bei zerebralen arteriovenosen missbildungen
45. Anatomical grading of supratentorial arteriovenous mafformations for determining operability
46. The relevance of anatomic and hemodynamic factors to a classification of cerebral arteriovenous malformations
47. Surgical vs conservative treatment of intracranial arteriovenous malformations: A study in surgical decision-making
48. Classification of supratentorial arteriovenous malformations: A score system for evaluation of operability and surgical strategy based on an analysis of 66 cases
49. Cerebral arteriovenous malformations: Factors influencing the surgical difficulty and outcome
50. Evaluation of prognostic factors in cerebral arteriovenous malformations
51. Grading of supratentorial arteriovenous malformations on the basis of multivariate analysis of prognostic factors
52. Relationship of perfusion pressure and size to risk of hemorrhage from arteriovenous malformations
53. Hypertension does not cause spontaneous hemorrhage of intracranial arteriovenous malformations
54. Columbia University AVM Study Project. Arteriovenous malformation draining vein physiology and determinants of transnidal pressure gradients
55. Anesthetic considerations
56. Neuroanesthesia considerations for surgical and endovascular therapy of arteriovenous malformations
57. Is there still a place for routine deep hypocapnia in intracranial surgery?
58. Mild hypothermia as a protective therapy during intracranial aneurysm surgery: A randomized prospective pilot trial
59. Cerebral hyperemia after AVM resection is related to "breakthrough" complications but not to feeding artery, pressure
60. Analysis of catecholamine and vasoactive peptide release in intracranial arterial venous malformations
61. Effect of mild byperthermia on the ischemic infarct volume after middle cerebral artery, occlusion in the rat
62. Deliberate mild intraoperative hypothermia for craniotomy
63. Unruptured intracranial aneurysms and arteriovenous malformations: Frequency of intracranial hemorrhage and relationship of lesions
64. Report on the cooperative study of intracranial aneurysms and subarachnoid hemorrhage, section VI: Arteriovenous malformations: An analysis of 545 cases of crania-cerebral arteriovenous malformations and fistulae reported to the cooperative study
65. Cerebral arteriovenous malformations: Considertions for and experience with surgical treatment in 166 cases
66. Hyperemic and ischemic problems of surgical treatment of arteriovenous malformations
67. Hemodynamic aspects of cerebral arteriovenous malformations
68. Radical surgery in cerebral AVM: Tactical procedures based upon hemodynamic factors
69. Intracerebral venous angioma: Case report and review
70. Microsurgical treatment of intracranial vascular malformations
71. Cerebral circulation during arteriovenous malformation operation
72. The use of acetazolamide-enhanced regional cerebral blood flow measurement to predict risk to arteriovenous malformarion patients
73. Cerebrovascular hemodynamics in arteriovenous malformation complicated by normal peffusion pressure breakthrough
74. Cerebral hemodynamics in angioma patients: An intraoperative study
75. Pressure autoregulation is intact after arteriovenous malformation resection
76. Evidence for adaptive autoregulatory displacement in hypotensive cortical territories adjacent to arteriovenous malformations
77. The effect of arteriovenous malformation resection on cerebrovascular reactivity to carbon dioxide
78. 133Xe blood flow monitoring during arteriovenous malformation resection: A case of intraoperative hyperperfusion with subsequent brain swelling
79. The case against staged operative resection of cerebral arteriovenous malformations
80. Occlusive hyperemia: A theory for the hemodynamic complications following resection of intracerebral arteriovenous malformations
81. Occlusive hyperemia: A new way to think about an old problem
82. Quantitation of altered hemodynamics
83. Convenient preparations of ready-to-use particles in polyvinyl alcohol foam suspension for embolization
84. Preoperative embolization of brain AVMs using surgical silk and polyvinyl alcohol
85. Polyvinyl alcohol foam-Gelfoam for therapeutic embolization: A synergistic mixture
86. Endovascular treatment of intracerebral arteriovenous malformations: Experience in 49 cases
87. The pathology of arteriovenous malformations of the brain treated by embolotherapy, II: Results of embolization with multiple agents
88. The safety and effectiveness of brain arteriovenous malformation embolization using acrylic and particles: The experiences of a single institution
89. Embolization with n-butyl cyanoacrylate in the management of CNS vascular lesions
90. Preoperative embolization of brain AVMs with isobutyl-2-cyanoacrylate
91. Use of a new mixture for embolization of intracranial vascular malformations: Preliminary experimental experience
92. Therapeutic alternatives for vein of Galen vascular malformations
93. Ivalon-33% ethanol-avitene embolic mixture: Clinical experience with neuroradiological endovascular therapy in 40 arteriovenous malformations
94. Use of ethanol in preoperative AVM embolization
95. Symptomatic vascular malformations: Ethanol embolotherapy
96. Feeding artery pedicle aneurysms; association with parenchymal hemorrhage and arteriovenous malformation in the brain
97. Interventional neuroradiology and minimally invasive neurosurgery
98. Anesthesia for interventional neuroradiology
99. Anesthetic considerations for interventional neuroradiology
100. Anterior translocation of language in patients with left cerebral arteriovenous malformations
101. Functional magnetic resonance imaging of regional brain activity in patients with intracerebral arteriovenous malformations before surgical or endovascular therapy
102. Conscious sedation for interventional neuroradiology: A comparison of midazolam and propofol infusion
103. Interventional neuroradiology
104. Management of hemorrhagic complications from preoperative embolization of arteriovenous malformations
105. Adenosine-induced cardiac pause for endovascular embolization of cerebral arteriovenous malformations: Technical case report
106. Treatment of cerebral arteriovenous malformations: Combined neurosurgical and neuroradiologic approach
107. Ethanol embolization of vascular malformations
108. Preoperative embolization of cerebral arteriovenous malformations with polyvinyl alcohol particles: Experience in 51 adults
109. Surgical management of large AVM's by staged embolization and operative excision
110. Combined endovascular embolization and surgery, in the management of cerebral arteriovenous malformations: Experience with 101 cases
111. The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations
112. Angiographic follow-up of large cerebral AVMs incompletely embolized with isobutyl-2-cyanoacrylate
113. The hemodynamic changes measured in cerebral arterio-venous malformations following endovascular treatment
114. Intraarterial sodium Amytal administration to guide pre-operative embolization of cerebral arteriovenous malformations
115. Arteriovenous malformations of the brain: Choosing embolic materials to enhance safety and ease of excision
116. Outcome analysis of preoperative embolization with N-butyl cyanoacrylate in cerebral arteriovenous malformations
117. Treatment of arteriovenous malformations of the brain with combined embolization and stereotactic radiosurgery: Results after 1 and 2 years
118. Cranial arteriovenous malformations: The role of embolization and stereotactic surgery
119. Treatment of brain arteriovenous malformations by embolization and radiosurgery
120. Revascularization of brain arteriovenous malformations after embolization with bucrylate
121. Dissolution of isobutyl 2-cyanoacrylate on long-term follow-up
122. Repeat stereotactic radiosurgery of arteriovenous malformations: Factors associated with incomplete obliteration
123. Rolandic arteriovenous malformations: Improvement in limb function by IBC embolization
124. Dominant-hemisphere arteriovenous malformations: Therapeutic embolization with isobutyl-2-cyanoacrylate
125. Occlusion of cerebral arteriovenous malformations with n-butyl cyano-acrylate is permanent
126. Radiation therapy for arteriovenous malformations: A review
127. Stereotactic radiosurgery for arteriovenous malformations of the brain
128. Clinical outcome of radiosurgery for cerebral arteriovenous malformations
129. Linear accelerator radiosurgery of cerebral artefiovenous malformations: An update
130. Seizure outcome in children treated for arteriovenous malformations using gamma knife radiosurgery
131. Linear accelerator radiosurgery for arteriovenous malformations: The relationship of size to outcome
132. Long-term angiographic outcome of arteriovenous malformations responding incompletely to gamma knife surgery
133. Stereotactic heavy-charged-particle Bragg-peak radiation for intracranial arteriovenous malformations
134. Interim report on the radiosurgical treatment of cerebral arteriovenous malformations: The influence of size, dose, time, and technical factors on obliteration rate
135. Patient outcomes after stereotactic radiosurgery for "operable" arteriovenous malformations
136. A dose-response analysis of arteriovenous malformation obliteration after radiosurgery
137. Analysis of neurological sequelae from radiosurgery of arteriovenous malformations: How location affects outcome
138. Stereotactic radiosurgery for postgeniculate visual pathway arteriovenous malformations
139. Gamma knife radiosurgery for arteriovenous malformations: Long-term follow-up results focusing on complications occurring more than 5 years after irradiation
140. Effects of gamma knife surgery on the risk of rupture prior to AVM obliteration
141. The risk of hemorrhage after radiosurgery for arteriovenous malformations
142. Hemorrhage risk after stereotactic radiosurgery of cerebral arteriovenous malformations
143. Multimodality treatment of deep arteriovenous malformations: Thalamus, basal ganglia, and brain stem
144. Cerebral vascular disease in pregnancy, I: Haemorrhage
145. Arteriovenous malformations, aneurysms, and pregnancy
146. Subarachnoid hemorrhage in pregnancy
147. Pregnancy and the risk of hemorrhage from cerebral arteriovenous malformations
148. Vascular malformations and pregnancy
149. Arterio-venous malformations in childhood: Clinical presentation, results after operative treatment and long-term followup
150. Comparison of pediatric and adult cerebral arteriovenous malformations
151. Cerebral arteriovenous malformations in children: Clinical features and outcome of treatment in children and in adults
152. Recurrent cerebral arteriovenous malformations after negative postoperative angiograms
153. Report of joint committee for stroke facilities, IX: Strokes in children, I
154. Natural history of subarachnoid hemorrhage, intracranial aneurysms, and arteriovenous malformations: Based on 6368 cases in the cooperative study
155. Choices in the 1990s for the management of pediauic cerebral arteriovenous malformations
156. Hydrocephalus and congestive heart failure caused by intracranial arteriovenous malformations in infants
157. Circulation in neonates with intracranial arteriovenous fistula and cardiac failure
158. Congestive cardiac manifestations from cerebrocranial arteriovenous shunts: Endovascular management in 30 children
159. Neonatal superficial cerebral arteriovenous malformations
160. Nongalenic cerebral arteriovenous malformations in neonates and infants: Review of 26 consecutive cases (1982-1992)
161. Deep-seated giant arteriovenous malformations in infancy
162. Arteriovenous malformations of the brain in children: A forty-year experience
163. Cerebral arteriovenous malformations in children: Management of 179 consecutive cases and review of the literature
164. The management of arteriovenous malformations in children
165. Pediatric cerebral arteriovenous malformations: A management outcome comparison with an adult cohort
166. Multimodality treatment in pediatric AVMs improves outcome
167. Cerebral arteriovenous malformations in children and adolescents
168. Intracranial arteriovenous malformations in childhood
169. Cerebral arteriovenous malformations in children
170. Surgical experience with arteriovenous malformations in children
171. The results of operating upon cerebral aneurysms and angiomas in children and adolescents, II: Cerebral angiomas
172. Endovascular treatment of pial AVMs: Technical options, indications and limits in pediatric age patients
173. Gamma knife radiosurgery for intracranial arteriovenous malformations in childhood and adolescence
174. Stereotactic radiosurgery in children
175. Stereotactic heavy-charged-particle Bragg peak radiosurgery for the treatment of intracranial arteriovenous malformations in childhood and adolescence
176. Stereotactic radiosurgery for the treatment of arteriovenous malformations in childhood
177. Radiosurgery for cerebral AVMs in children and adolescents: The neurobehavioral outcome
178. Combined management of intracranial vascular malformations in children
179. Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations: An immunocytochemical study
180. Long-term follow-up of seizures associated with cerebral arteriovenous malformations: Results of therapy
181. Surgical management of epilepsy associated with cerebral arteriovenous malformations
182. Seizure outcome in patients with surgically treated cerebral arteriovenous malformations
183. Seizure control after surgery on cerebral artetiovenous malformations
184. Relief of epilepsy by radiosurgery of cerebral arteriovenous malformations